Daily non-political popular news in brief.

Novel gallium compound may offer treatment for lymphoma patients with resistant disease

Christopher Chitambar, M.D., a physician researcher at the Medical College of Wisconsin Cancer Center in Milwaukee, has identified a compound that may be effective in treating forms of non-Hodgkin's lymphoma (a cancer of the lymphatic system) that are resistant to certain therapies. The new agent could also offer the advantages of being administered orally, rather than intravenously, making it more convenient than intravenous agents.

Read more »

Keywords: novel, gallium, compound, offer, treatment, lymphoma, patients, resistant, disease, patient

« Previous | Next »

Similar news on "Novel gallium compound may offer treatment for lymphoma patients with resistant disease":

1. Phase II study shows HRPC patients with bone metastases see improved survival with ZD4054
   09-25-2007 · EurekAlert!
   New Phase II data presented today suggest that ZD4054, a novel compound in development for the treatment of men with hormone-resistant prostate cancer, could offer a promising improvement in overall survival in men with metastatic HRPC who were asymptomatic or mildly symptomatic for pain.1 Patients who received ZD4054 10mg once-daily experienced a 45 percent reduction in the risk of death compared to placebo.
   Similar news · Read more »
   
2. Patient adherence for successful tuberculosis treatment
   03-27-2007 · EurekAlert!
   Existing treatment against Tuberculosis is effective but long and many patients abandon it before the end or take their doses at excessively long intervals. In order to improve patients' adherence to treatment, IRD researchers are putting the emphasis on adaptation of control strategies to patients' real geographical, social, health and cultural situation. Trials conducted in Senegal showed the effectiveness of such an approach, which should limit the spread of the disease and the emergence of new resistant strains.
   Similar news · Read more »
   
3. How do patients choose the best treatment for their disease?
   10-03-2007 · EurekAlert!
   The diagnosis has come in, and it's not good. Worse, the patient has to choose from treatment options that are sometimes contradictory and risky. None of them promises complete success. How do patients make an informed decision, choosing the very best treatment for their own healthcare?
   Similar news · Read more »
   
4. Researchers wake up viruses inside tumors to image and then destroy cancers
   03-01-2007 · EurekAlert!
   Researchers have found a way to activate Epstein-Barr viruses inside tumors as a way to identify patients whose infection can then be manipulated to destroy their tumors. They say this strategy could offer a novel way of treating many cancers associated with Epstein-Barr, including at least four different types of lymphoma and nasopharyngeal and gastric cancers.
   Similar news · Read more »
   
5. Study finds limited options for backup HIV treatment in some developing countries
   01-08-2007 · EurekAlert!
   Thai researchers have discovered that patients who fail treatment with a commonly used, inexpensive, first-line antiretroviral therapy (ART) are also usually resistant to other, similar drugs, leaving progressively fewer options for replacement therapies. Since catching treatment failure early is key to preventing further resistance, this research, published in the February 1 issue of Clinical Infectious Diseases also argues for greater access in the developing world to tests that detect when the amount of virus in a patient's blood is increasing.
   Similar news · Read more »
   
6. Treatment with Belimumab showed improvement in symptoms in 46 percent of lupus patients at 52 weeks
   06-14-2007 · EurekAlert!
   Treatment with belimumab resulted in a sustained improvement of systemic lupus erythematosus disease activity in 46 percent of patients at week 52, according to a novel combined responder index in results presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.
   Similar news · Read more »
   
7. Israeli scientists identify: Genes that affect responses of multiple sclerosis patients to copaxone
   10-10-2007 · EurekAlert!
   Getting the drug dosage correct can be a tricky exercise in trial and error in a disease like multiple sclerosis. Scientists from the Weizmann Institute and the Technion have identified two genes that affect a patient's response to the drug Copaxone, a finding which may help take the some of the guesswork out of treatment.
   Similar news · Read more »
   
8. Hepatitis B drug can compromise HIV treatment
   06-20-2007 · EurekAlert!
   Treating hepatitis B patients with the drug entecavir can cause those who are also infected with HIV to become resistant to two of the most important drugs in the anti-HIV arsenal. In findings published in the New England Journal of Medicine, researchers reported that a patient infected with both hepatitis B and HIV who was treated with entecavir developed a mutant strain of HIV that is resistant to the antiviral drugs lamivudine and emtricitabine.
   Similar news · Read more »
   
9. New research may overturn conventional wisdom on drug-resistant tuberculosis
   02-20-2007 · EurekAlert!
   A newly released study suggests that the majority of cases of drug-resistant tuberculosis (TB) among patients undergoing treatment for the disease may be due to new infections, not acquired resistance. If confirmed in future studies the research, in the March 15 issue of the Journal of Infectious Diseases, may drive a major shift in strategy for controlling TB.
   Similar news · Read more »
   
10. New biologic treatment for tennis elbow may replace surgery for chronic sufferers
    10-23-2006 · EurekAlert!
    "Tennis elbow" isn't restricted to tennis players; it's a common, chronic problem for people whose activities require strong gripping or repetitive wrist motions. A novel biologic treatment of injecting the patient's own platelets into the affected tendon proves successful and gives patients another treatment option before undergoing surgery. The procedure has wide application for healing of other medical conditions, say researchers from Stanford University.
    Similar news · Read more »